EAACI Congress 2024: นวัตกรรมและความก้าวหน้าในการรักษาโรคภูมิแพ้
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
ในระหว่างการประชุมจะมีการนำเสนอเซสชันทางวิทยาศาสตร์มากกว่า 150 ครั้ง โดยมุ่งเน้นที่ความก้าวหน้าทางวิทยาศาสตร์สิ่งแวดล้อม โรคภูมิแพ้อาหาร นวัตกรรมในการใช้ภูมิคุ้มกันบำบัดและโรคภูมิแพ้ในเด็ก และอื่นๆ...
Congreso EAACI 2024: Innovación y Avances en el Tratamiento de Alergias
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
Durante el congreso se presentarán más de 150 sesiones científicas centradas en los avances en ciencia medioambiental, alergias alimentarias, innovaciones en inmunoterapia o alergias pediátricas,...
קונגרס EAACI 2024: חדשנות והתקדמות בטיפול באלרגיה
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
במהלך הקונגרס יוצגו למעלה מ-150 מושבים מדעיים, שיתמקדו בין היתר בהתקדמות במדעי הסביבה, אלרגיות למזון, חידושים באימונותרפיה ואלרגיות ילדים.רפואה מדויקת, בינה מלאכותית, אימונותרפיה ומודולטורים...
Lifeist Reports First Quarter 2024 Financial Results
April 29, 2024 20:58 ET
|
Lifeist Wellness Inc.
Q1 2024 Financial Results
Empowering Families: May Recognized as Women's Health Awareness Month with a Focus on Pediatric Gastroenterology
April 29, 2024 08:40 ET
|
GI Alliance
Frisco, TX, April 29, 2024 (GLOBE NEWSWIRE) -- As we approach Women’s Health Awareness Month in May, GI Alliance – the leading physician-owned and -led network of gastroenterology practices in the...
GI Alliance Supports Women’s Health Awareness Month: A Focus on Colorectal Health
April 29, 2024 08:35 ET
|
GI Alliance
Glenview, IL, April 29, 2024 (GLOBE NEWSWIRE) -- As we approach Women’s Health Awareness Month in May, GI Alliance – the leading physician-owned and -led network of gastroenterology practices in the...
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Steffan Dalsgaard, CEO of Golden Triangle Ventures Inc.
April 29, 2024 08:17 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, April 29, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce...
MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung Disease
April 29, 2024 06:05 ET
|
MannKind
MANNKIND ANNOUNCES IND CLEARANCE FROM U.S. FDA TO START PHASE 3 STUDY OF CLOFAZIMINE INHALATION SUSPENSION FOR NTM LUNG DISEASE
Dr. Scharles Konadu Joins TDDC in Fort Worth
April 24, 2024 08:40 ET
|
GI Alliance
Fort Worth, TX, April 24, 2024 (GLOBE NEWSWIRE) -- Texas Digestive Disease Consultants is excited to welcome Dr. Scharles Konadu, a multi-talented rising star in the gastroenterology field who...
Aspen Ideas: Health Announces Global Health Experts to Speak at Annual Summit
April 23, 2024 09:56 ET
|
The Aspen Institute
Aspen, CO & Washington, DC, April 23, 2024 (GLOBE NEWSWIRE) -- On Friday, the organizers of the Aspen Institute’s annual health summit, Aspen Ideas: Health, announced additional speakers joining...